Phil Mickelson has created quite the news on the second-round of Masters telecast where he pulled out a small vial from his golf bag, squirted a liquid into his mouth and tucked the vial back in his bag. Many people have already watched the viral YouTube video, which ignited speculation that Mickelson might have been the latest Tour pro to join the CBD bandwagon.
Several pros like Brandt Jobe, Bubba Watson, Charley Hoffman, Morgan Hoffmann and Scott McCarron, have signed up for endorsement deals with CBD manufactures. CBD or cannabinoidal is a rapidly growing category distinct from medical marijuana, which is derived from pure, natural hemp plant, a cannabis genus plant.
CBD has garnered immense popularity because of its gamut of medical benefits. It is known to treat anxiety, depression, panic attacks, seizures in epilepsy, insomnia, acute pain, chronic aches, inflammation, swelling and even severe diseases such as cancer, tourettes and Alzheimer’s. However these are simply medical claims of CBD and while there are many studies and research that support them, law enforcement agencies still remain skeptical about the safety and effectiveness of CBD.
Manufacturers are not allowed to advertise any medical claims with CBD products as it is prohibited by the U.S. Food and Drug Administration. The agency has been issuing warning letters to companies that market their CBD based products as a cure for ailments or alternatives to prescription based medicines.
The stringent regulations by the FDA has deterred many Tour players from giving CBD a try.
Hoffmann was diagnosed with muscular dystrophy in 2016, he then went to Nepal last year for his four months of herbal therapy sessions. Soon after he returned, Medterra CBD contacted Hoffmann and he has been using its products ever since.
Hoffmann explains that after taking CBD, he has not had any injuries, and his body is rejuvenated with a calm mind.
Despite that the World Anti-Doping Agency has removed CBD from its life of controlled substances earlier this year in January, the PGA Tour remains wary. In April, the Tour warned players that some CBD products might contain traces of THC, which could result in a positive drug test.
Hoffmann says that he had alerted the Tour of his future plans with CBD and was advised to be careful about the source of cannabinoid as any traces of THC could land him up in a crucial situation with no one else to take ownership of it, but him.
The FDA held a public meeting on May 31 with stakeholders, business leaders, consumers, marketers, industrialists, manufacturers, and others to discuss the regulatory framework for CBD. The agency is firm in its decision of first evaluating the aftermath of CBD instead of waving off a positive sign to companies to flood the market with CBD products.
A spokesperson from the FDA said the public’s health safety is the utmost priority for the agency as always and it will not promote or allow any marketing of CBD products unless they’re fully researched and checked for their quality.
But, despite the efforts of the FDA to control and regulate CBD products, companies have been exploding the market with CBD products. Worldwide Golf Shops recently announced their partnership with Medterra. Another famous company, Functional Remedies, which sponsors McCarron, has launched its CBD products in pro shops, according to Steve Patterson, who looks after the sales of the company.
Dr. Larry McCleary, an advisor to Boomer Natural Wellness, a CBD manufacturer, said that the medical community is all over CBD to find out its safety and effectiveness, and they’re gradually gaining acceptance.
The event that triggered CBD boom in the U.S. market was the Agricultural Improvement Act in December 2018, which removed hemp-derived cannabinoid from the list of controlled substances. The law has been a game changer for the CBD industry and the product is now flourishing the consumer market with products ranging from skin care and beauty to fitness and wellness.
Jay Hartenbach, the CEO of Medterra CBD said growing hemp is legal on a federal level now and farmers have responded positively by ramping up their hemp production. The higher the cultivation of natural hemp, the more prices could go down for CBD products, that are a bit expensive as compared to conventional over-the-counter medications.
Hartenbach added that it seems that CBD has made space for itself in the mainstream America and consumers are now receptive to CBD.
CBD has been long associated with marijuana, and high causing compounds like THC, tetrahydro cannabinoid which is responsible for causing hallucinations when people smoke weed or pot. However, the federal regulations has cleared off CBD for any psychoactive effects and made it legal. As for THC, the highest limit for THC per product is 0.3%, above which the product becomes illegal and unlawful to produce, process, market, sell or possess.